Early Decision Making in a Randomized Phase II Trial of Atezolizumab in Biliary Tract Cancer Using a Tumor Growth Inhibition-Survival Modeling Framework.

Shemesh, Colby S; Chan, Phyllis; Marchand, Mathilde; Gonçalves, Antonio; Vadhavkar, Shweta; Wu, Benjamin; Li, Chunze; Jin, Jin Y; Hack, Stephen P; Bruno, Rene

Shemesh, Colby S; Chan, Phyllis; Marchand, Mathilde; Gonçalves, Antonio; Vadhavkar, Shweta; Wu, Benjamin; Li, Chunze; Jin, Jin Y; Hack, Stephen P; Bruno, Rene.

Affiliation

Shemesh CS; Clinical Pharmacology, Genentech Inc., South San Francisco, California, USA.
Chan P; Clinical Pharmacology, Genentech Inc., South San Francisco, California, USA.
Marchand M; Certara Strategic Consulting, Paris, France.
Gonçalves A; Certara Strategic Consulting, Paris, France.
Vadhavkar S; Clinical Pharmacology, Genentech Inc., South San Francisco, California, USA.
Wu B; Clinical Pharmacology, Genentech Inc., South San Francisco, California, USA.
Li C; Clinical Pharmacology, Genentech Inc., South San Francisco, California, USA.
Jin JY; Clinical Pharmacology, Genentech Inc., South San Francisco, California, USA.
Hack SP; Product Development Oncology, Genentech Inc., South San Francisco, California, USA.
Bruno R; Clinical Pharmacology, Genentech-Roche, Marseille, France.

Clin Pharmacol Ther ; 114(3): 644-651, 2023 09.

Article de En | MEDLINE | ID: mdl-37212707

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs des voies biliaires / Tumeurs du foie Type d'étude: Clinical_trials / Etiology_studies / Prognostic_studies Limites: Humans Langue: En Journal: Clin Pharmacol Ther Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google